A detailed history of Strategic Investment Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Strategic Investment Advisors holds 10,065 shares of MRK stock, worth $1.06 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,065
Previous 10,412 3.33%
Holding current value
$1.06 Million
Previous $1.29 Million 11.4%
% of portfolio
0.13%
Previous 0.16%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$111.15 - $128.97 $38,569 - $44,752
-347 Reduced 3.33%
10,065 $1.14 Million
Q2 2024

Jul 22, 2024

SELL
$123.8 - $132.96 $3,837 - $4,121
-31 Reduced 0.3%
10,412 $1.29 Million
Q1 2024

Apr 22, 2024

BUY
$113.24 - $131.95 $12,343 - $14,382
109 Added 1.05%
10,443 $1.38 Million
Q4 2023

Jan 10, 2024

SELL
$100.18 - $109.02 $153,175 - $166,691
-1,529 Reduced 12.89%
10,334 $1.13 Million
Q3 2023

Oct 24, 2023

BUY
$102.95 - $114.33 $21,516 - $23,894
209 Added 1.79%
11,863 $1.22 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $270,656 - $295,002
2,492 Added 27.2%
11,654 $1.34 Million
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $307,275 - $342,857
-2,985 Reduced 24.57%
9,162 $974,000
Q4 2022

Jan 19, 2023

BUY
$87.44 - $112.11 $262 - $336
3 Added 0.02%
12,147 $0
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $33,727 - $37,889
399 Added 3.4%
12,144 $1.05 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $131,162 - $148,679
-1,571 Reduced 11.8%
11,745 $1.07 Million
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $244,053 - $273,568
3,320 Added 33.21%
13,316 $1.09 Million
Q4 2021

Jan 26, 2022

BUY
$72.28 - $90.54 $130,537 - $163,515
1,806 Added 22.05%
9,996 $766,000
Q3 2021

Oct 19, 2021

BUY
$71.68 - $78.83 $46,807 - $51,475
653 Added 8.66%
8,190 $615,000
Q2 2021

Jul 22, 2021

SELL
$70.31 - $77.77 $283,068 - $313,102
-4,026 Reduced 34.82%
7,537 $586,000
Q1 2021

Apr 14, 2021

SELL
$68.86 - $81.11 $848,561 - $999,518
-12,323 Reduced 51.59%
11,563 $891,000
Q4 2020

Jan 13, 2021

BUY
$71.77 - $79.65 $933,153 - $1.04 Million
13,002 Added 119.46%
23,886 $1.95 Million
Q3 2020

Oct 14, 2020

BUY
$73.18 - $82.95 $248,958 - $282,195
3,402 Added 45.47%
10,884 $903,000
Q2 2020

Aug 04, 2020

BUY
$70.42 - $80.13 $29,365 - $33,414
417 Added 5.9%
7,482 $579,000
Q1 2020

Apr 13, 2020

BUY
$63.36 - $87.82 $196,479 - $272,329
3,101 Added 78.23%
7,065 $544,000
Q4 2019

Jan 23, 2020

BUY
$77.58 - $87.54 $26,842 - $30,288
346 Added 9.56%
3,964 $360,000
Q3 2019

Oct 25, 2019

BUY
$76.08 - $82.93 $32,942 - $35,908
433 Added 13.59%
3,618 $305,000
Q2 2019

Jul 23, 2019

BUY
$69.84 - $81.59 $31,428 - $36,715
450 Added 16.45%
3,185 $266,000
Q1 2019

Apr 30, 2019

BUY
$69.58 - $79.36 $190,301 - $217,049
2,735 New
2,735 $227,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $266B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Strategic Investment Advisors Portfolio

Follow Strategic Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.